A detailed history of Riverview Trust CO transactions in Dexcom Inc stock. As of the latest transaction made, Riverview Trust CO holds 463 shares of DXCM stock, worth $37,303. This represents 0.03% of its overall portfolio holdings.

Number of Shares
463
Previous 231 100.43%
Holding current value
$37,303
Previous $26,000 19.23%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$64.0 - $116.06 $14,848 - $26,925
232 Added 100.43%
463 $31,000
Q1 2024

Apr 12, 2024

BUY
$114.22 - $140.1 $26,384 - $32,363
231 New
231 $32,000
Q3 2022

Oct 27, 2022

BUY
$76.35 - $94.18 $12,597 - $15,539
165 New
165 $13,000
Q2 2022

Jul 27, 2022

SELL
$67.99 - $132.89 $3,263 - $6,378
-48 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$94.08 - $130.2 $4,515 - $6,249
48 New
48 $25,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.